Cover Image
市場調查報告書

肌抽躍發作:全球臨床實驗檢討

Myoclonic Seizures Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 308259
出版日期 內容資訊 英文 57 Pages
訂單完成後即時交付
價格
Back to Top
肌抽躍發作:全球臨床實驗檢討 Myoclonic Seizures Global Clinical Trials Review, H2, 2014
出版日期: 2014年07月14日 內容資訊: 英文 57 Pages
簡介

本報告提供肌抽躍發作相關臨床研究之最新趨勢分析,提供您疾病治療方法概要,及臨床實驗的主要國家──G7各國及E7(新興7個國家)的臨床實驗數及實驗對像採用狀況,地區、Phase、階段別進展,有潛力的贊助商,再彙整各企業研究機關的研究進展,有潛力的藥劑比較等資訊。

目錄

簡介

  • 肌抽躍發作
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東及非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統臨床實驗數量中,肌抽躍發作臨床實驗數量所佔的比例

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:進展狀況別

E7(新興7個國家)各國臨床實驗數量:中樞神經系統臨床實驗數量中,肌抽躍發作臨床實驗數量所佔的比例

E7(新興7個國家)各國臨床實驗數量:Phase別

E7(新興7個國家)各國臨床實驗數量:進展狀況別

Phase別臨床實驗數量

  • 進行中的臨床實驗:Phase別

各進展狀況臨床實驗數量

試驗指標達成狀況別臨床實驗數量

尚未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • UCB S.A.
    • Biocodex SA
    • Teva Pharmaceutical Industries Limited
    • Sky Growth Acquisition Corporation
    • GW Pharmaceuticals plc
    • Eisai
    • Desitin Arzneimittel GmbH
    • Bluefish Pharmaceuticals AB
    • Adamed Sp. z o.o.
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Institute of Neurological Disorders and Stroke
    • University of Colorado Denver
    • 靜岡大學
    • Institut National de la Sante et de la Recherche Medicale
    • University of Turku

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2239CTIDB

GlobalData's clinical trial report, "Myoclonic Seizures Global Clinical Trials Review, H2, 2014" provides data on the Myoclonic Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myoclonic Seizures. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myoclonic Seizures. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Myoclonic Seizures
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Myoclonic Seizures
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Myoclonic Seizures Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • UCB S.A.
      • Clinical Trial Overview of UCB S.A.
      • Biocodex SA
      • Clinical Trial Overview of Biocodex SA
      • Teva Pharmaceutical Industries Limited
      • Clinical Trial Overview of Teva Pharmaceutical Industries Limited
      • Sky Growth Acquisition Corporation
      • Clinical Trial Overview of Sky Growth Acquisition Corporation
      • GW Pharmaceuticals plc
      • Clinical Trial Overview of GW Pharmaceuticals plc
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • Desitin Arzneimittel GmbH
      • Clinical Trial Overview of Desitin Arzneimittel GmbH
      • Bluefish Pharmaceuticals AB
      • Clinical Trial Overview of Bluefish Pharmaceuticals AB
      • Adamed Sp. z o.o.
      • Clinical Trial Overview of Adamed Sp. z o.o.
    • Clinical Trial Overview of Top Institutes / Government
      • National Institute of Neurological Disorders and Stroke
      • Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
      • University of Colorado Denver
      • Clinical Trial Overview of University of Colorado Denver
      • Shizuoka University
      • Clinical Trial Overview of Shizuoka University
      • Institut National de la Sante et de la Recherche Medicale
      • Clinical Trial Overview of Institut National de la Sante et de la Recherche Medicale
      • University of Turku
      • Clinical Trial Overview of University of Turku
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Myoclonic Seizures Therapeutics, Global, Clinical Trials by Region, 2014*
  • Myoclonic Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Myoclonic Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Myoclonic Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Myoclonic Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Myoclonic Seizures Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Myoclonic Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Myoclonic Seizures Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Myoclonic Seizures Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Myoclonic Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Myoclonic Seizures Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Myoclonic Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Biocodex SA, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Sky Growth Acquisition Corporation, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Desitin Arzneimittel GmbH, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Adamed Sp. z o.o., 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado Denver, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Shizuoka University, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut National de la Sante et de la Recherche Medicale, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Turku, 2014*

List of Figures

  • Myoclonic Seizures Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Myoclonic Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Myoclonic Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Myoclonic Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Myoclonic Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Myoclonic Seizures Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Myoclonic Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Myoclonic Seizures Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Myoclonic Seizures Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Myoclonic Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Myoclonic Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Myoclonic Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top